Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6006349 | Clinical Neurology and Neurosurgery | 2016 | 21 Pages |
Abstract
This exploratory study suggests that the SMP-a might be a feasible rating scale in patients with intracranial tumors. The flexibility of the scale enables individual adaption, but preserves the standardized scoring system to allow comparison between assessment dates, patients and, hopefully in the future, institutions. However, future studies are mandatory to provide data on the instrument's diagnostic properties with respect to feasibility, objectivity, validity and reliability.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Juliane Becker, Margit Jehna, Elisabeth Steinmann, Hubertus M. Mehdorn, Michael Synowitz, Gesa Hartwigsen,